Quicker Cures: How Insilico Medicine Uses Generative AI to Accelerate Drug Discovery

	Quicker Cures: How Insilico Medicine Uses...

While generative AI is a relatively new household term, drug discovery company Insilico Medicine has been using it for years to develop new therapies for debilitating diseases. The company’s early bet on deep learning is bearing fruit — a drug candidate discovered using its AI platform is now entering Phase 2 clinical trials to treat Read article >

- View Press Release
- Visit NVIDIA Corporation

Posted: June 27, 2023 | By: Wissen Schwamm

Recent NVIDIA related news.

NVIDIA Nemotron 3.5 Lightning and NeMo Switchyard Deliver Faster, Smarter, More Efficient Agentic AI

NVIDIA and Local AI Community Fuel Open Source Models and Intelligent Agents

Why Scaling AI Compute Performance Requires a New Power Architecture

NVIDIA Partners With Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR to Establish AI Compute Infrastructure Financing Platforms to Mobilize Over $500 Billion of Third-Party Capital

Firebird Launches CIS Region’s Largest AI Factory in Armenia

+ View more NVIDIA related news +

			More Technical Information Than You Can Handle.

Quicker Cures: How Insilico Medicine Uses...